日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score

针对接受免疫治疗的不可切除肝细胞癌患者，开发一种新的1年生存预后评分：ALIVE-IO评分

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1648248
Pantzios, Spyridon; Sidiropoulos, Orestis; Syriha, Antonia; Ptohis, Nikolaos; Skouras, Ioannis; Mainta, Evgenia; Korkolis, Dimitris P; Machairas, Nikolaos; Sotiropoulos, Georgios C; Elefsiniotis, Ioannis
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Impact of neutrophil-to-lymphocyte ratio on survival outcomes among cirrhotic and non-cirrhotic patients with advanced hepatocellular carcinoma under atezolizumab-bevacizumab combination therapy

中性粒细胞与淋巴细胞比值对接受阿特珠单抗-贝伐珠单抗联合治疗的晚期肝细胞癌肝硬化和非肝硬化患者生存结局的影响

期刊:Annals of Gastroenterology
影响因子:2.2
doi:10.20524/aog.2025.0963
Pantzios, Spyridon; Sidiropoulos, Orestis; Syriha, Antonia; Stathopoulou, Ioanna; Rellou, Sofia; Nychas, Emmanouil; Barla, Georgia; Ptohis, Nikolaos; Elefsiniotis, Ioannis
肿瘤
中性粒细胞
肿瘤免疫
粒细胞
肝硬化
细胞生物学
发表日期：2025
文献求助 收藏

Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels

血清维生素K缺乏诱导蛋白（PIVKA-II）、血清甲胎蛋白及其联合检测对诊断白种人肝硬化患者肝细胞癌的准确性，无论其血清甲胎蛋白水平是否具有诊断意义

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.6825
Syriha, Antonia; Pantzios, Spyridon; Mandilara, Dionysia; Galanis, Petros; Stathopoulou, Ioanna; Barla, Georgia; Elefsiniotis, Ioannis
细胞生物学
肿瘤
肝硬化
肿瘤免疫
发表日期：2024
文献求助 收藏

Efficacy of atezolizumab-bevacizumab combination therapy early after recurrence of hepatocellular carcinoma following resection or ablation with a curative intent

阿特珠单抗-贝伐珠单抗联合疗法在以根治为目的的肝细胞癌切除或消融术后复发早期疗效评估

期刊:Annals of Gastroenterology
影响因子:2.2
doi:10.20524/aog.2024.0916
Pantzios, Spyridon; Syriha, Antonia; Stathopoulou, Ioanna; Sidiropoulos, Orestis; Rellou, Sofia; Barla, Georgia; Ptohis, Nikolaos; Korkolis, Dimitris P; Sotiropoulos, Georgios C; Elefsiniotis, Ioannis
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Efficacy of Αtezolizumab-Βevacizumab in BCLC-C cirrhotic patients with hepatocellular carcinoma according to the type of disease progression, the type of BCLC-C and liver disease severity

根据疾病进展类型、BCLC C分期和肝病严重程度评估阿特珠单抗联合贝伐珠单抗治疗BCLC-C期肝硬化合并肝细胞癌患者的疗效

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-04846-4
Spyridon, Pantzios; Antonia, Syriha; Dionysia, Mandilara; Ioanna, Stathopoulou; Georgia, Barla; Nikolaos, Ptohis; Petros, Galanis; Ioannis, Elefsiniotis
肿瘤
肿瘤免疫
肝硬化
CLC
细胞生物学
发表日期：2023
文献求助 收藏